Literature DB >> 9766660

Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.

P Henderikx1, M Kandilogiannaki, C Petrarca, S von Mensdorff-Pouilly, J H Hilgers, E Krambovitis, J W Arends, H R Hoogenboom.   

Abstract

The tumor-associated antigen MUC1 is overexpressed and underglycosylated in human adenocarcinomas of diverse origins, such as breast, ovary, and colon. We isolated and describe five human single-chain (sc) Fv antibodies specific for the MUC1 variable number of tandem repeats region isolated by in vitro selection from a large naive phage antibody library containing over 6 x 10(9) different scFv antibodies. A synthetic biotinylated 100-mer peptide corresponding to five tandem repeats of the MUC1 peptide core was used for selection. Two of the antibodies were highly specific for MUC1 as judged by ELISA and flow cytometry. In immunohistochemistry, antibody clone 10A stained MUC1 in the cytoplasm and membrane of adenocarcinoma cells of breast and ovary, whereas in normal epithelium, only cytoplasmic or no staining was observed. With antibody clone 10B, staining was less pronounced and was not always membrane associated in adenocarcinoma. Determination of the fine specificity of 10A and 10B using a novel "indirect epitope fingerprinting" ELISA showed that both antibodies recognize unique epitopes that have not been described for hybridoma-derived anti-mucin antibodies of mouse origin. The selected human antibodies, like many of the murine MUC1 antibodies, recognize epitopes on the protein core of MUC1 that are abundantly present in the underglycosylated form of cell surface mucin on adenocarcinoma. The best human scFv, clone 10A, appears to distinguish normal cells from adenocarcinoma cells, which makes it an attractive candidate for use in antibody-based tumor targeting.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766660

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  A human immunoglobulin G1 antibody originating from an in vitro-selected Fab phage antibody binds avidly to tumor-associated MUC1 and is efficiently internalized.

Authors:  Paula Henderikx; Nicole Coolen-van Neer; Anita Jacobs; Edith van der Linden; Jan-Willem Arends; Jürgen Müllberg; Hennie R Hoogenboom
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

2.  Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors.

Authors:  N M Cirino; D Sblattero; D Allen; S R Peterson; J D Marks; P J Jackson; A Bradbury; B E Lehnert
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 3.  Designing immunotoxins for cancer therapy.

Authors:  Christopher A Pennell; Heidi A Erickson
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  Production and Evaluation of Specific Single-Chain Antibodies against CTLA-4 for Cancer-Targeted Therapy.

Authors:  Farideh Hosseinzadeh; Saeed Mohammadi; Foroogh Nejatollahi
Journal:  Rep Biochem Mol Biol       Date:  2017-10

5.  Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

Authors:  P Chames; S E Hufton; P G Coulie; B Uchanska-Ziegler; H R Hoogenboom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 6.  Prostate cancer relevant antigens and enzymes for targeted drug delivery.

Authors:  Ashutosh Barve; Wei Jin; Kun Cheng
Journal:  J Control Release       Date:  2014-05-27       Impact factor: 9.776

7.  Generation and characterization of human monoclonal scFv antibodies against Helicobacter pylori antigens.

Authors:  Nicole Reiche; Andreas Jung; Thomas Brabletz; Tanja Vater; Thomas Kirchner; Gerhard Faller
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

8.  Rise and fall of an anti-MUC1 specific antibody.

Authors:  Holger Thie; Lars Toleikis; Jiandong Li; Reinhard von Wasielewski; Gunther Bastert; Thomas Schirrmann; Isabel Tourais Esteves; Christian K Behrens; Bénédict Fournes; Nathalie Fournier; Christophe de Romeuf; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

9.  Natural and Induced Humoral Responses to MUC1.

Authors:  Silvia Von Mensdorff-Pouilly; Maria Moreno; René H M Verheijen
Journal:  Cancers (Basel)       Date:  2011-07-29       Impact factor: 6.639

10.  The human antibody fragment DIATHIS1 specific for CEACAM1 enhances natural killer cell cytotoxicity against melanoma cell lines in vitro.

Authors:  Maria L Dupuis; Valentina Fiori; Alessandra Soriani; Biancamaria Ricci; Sabrina Dominici; Diego Moricoli; Alessandro Ascione; Angela Santoni; Mauro Magnani; Maurizio Cianfriglia
Journal:  J Immunother       Date:  2015 Nov-Dec       Impact factor: 4.456

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.